Scandinavian Critical Care Trials Group Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2003
NCT00922714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Scandinavian Critical Care Trials Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Delirium (Phase 4)

Gastrointestinal Hemorrhage (Phase 4)

Hypoxia (Phase 3)

Sepsis (Phase 3)

Shock (Phase 4)

Shock, Septic (Phase 4)

Toxemia (Phase 3)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 13